Apie Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
BūstinėCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Įkurta2013
StatusasAktyvus
Patentai60 patentų
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Prisijunkite, kad matytumėte visus 60 patentus
Naršykite visą patentų portfelį su publikacijos numeriais, datomis ir šeimomis.
Prisijungti Sukurti paskyrą su savo el. paštuTai nemokama
Tęsdami sutinkate su Heelky Naudotojo sutartimi, Privatumo politika ir Slapukų politika.
Atsiliepimai
Atsiliepimų dar nėra. Dirbote su Onyx Pharmaceuticals, Inc.? Pasidalykite patirtimi pirmieji.
Teisinė informacija
| Juridinis pavadinimas | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Žiūrėti GLEIF ↗ |
| Registruotas adresas | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Statusas | Aktyvus |
Šaltiniai: GLEIF · atnaujinta 2026 m. spalio 16 d.
Kontaktai ir nuorodos
Vieta
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Ar tai jūsų įmonė?
Perimkite šį puslapį nemokamai, kad pridėtumėte logotipą, produktus, nuotraukas ir darbus bei atsakytumėte į atsiliepimus.
Perimti šį puslapįPrisijunkite prie Heelky, kad megztumėte ryšius, samdytumėte ir augtumėte
Sukurkite nemokamą paskyrą, kad rašytumėte žmonėms, teiktumėte paraiškas į darbus ir skelbtumėte misijas.
Prisijunkite dabar — tai nemokama